临床普外科电子杂志
臨床普外科電子雜誌
림상보외과전자잡지
Journal of General Surgery for Clinicians (Electronic Version)
2013年
4期
35-36,45
,共3页
韩嘉嘉%蔡洁%侯明晖%邵长卿
韓嘉嘉%蔡潔%侯明暉%邵長卿
한가가%채길%후명휘%소장경
强化胰岛素治疗%乳腺癌%糖尿病
彊化胰島素治療%乳腺癌%糖尿病
강화이도소치료%유선암%당뇨병
Intensive insulin therapy%Breast cancer%Diabetes
目的:观察围术期强化胰岛素治疗对乳腺癌合并糖尿病病人术后康复的疗效。方法选择2011年1月至2013年1月住院的乳腺癌合并糖尿病的手术病人120例,术前随机分成强化胰岛素治疗组及常规胰岛素治疗组,观察术后引流量、体温、伤口感染情况。结果术后24小时引流量两组间比较无明显差异(χ2=1.564 P=0.458);发热及伤口感染情况,强化胰岛素治疗组明显优于常规治疗组(χ2=6.274 P=0.043)。结论强化胰岛素治疗有利于乳腺癌合并糖尿病病人的术后切口愈合,明显减少并发症的发生。
目的:觀察圍術期彊化胰島素治療對乳腺癌閤併糖尿病病人術後康複的療效。方法選擇2011年1月至2013年1月住院的乳腺癌閤併糖尿病的手術病人120例,術前隨機分成彊化胰島素治療組及常規胰島素治療組,觀察術後引流量、體溫、傷口感染情況。結果術後24小時引流量兩組間比較無明顯差異(χ2=1.564 P=0.458);髮熱及傷口感染情況,彊化胰島素治療組明顯優于常規治療組(χ2=6.274 P=0.043)。結論彊化胰島素治療有利于乳腺癌閤併糖尿病病人的術後切口愈閤,明顯減少併髮癥的髮生。
목적:관찰위술기강화이도소치료대유선암합병당뇨병병인술후강복적료효。방법선택2011년1월지2013년1월주원적유선암합병당뇨병적수술병인120례,술전수궤분성강화이도소치료조급상규이도소치료조,관찰술후인류량、체온、상구감염정황。결과술후24소시인류량량조간비교무명현차이(χ2=1.564 P=0.458);발열급상구감염정황,강화이도소치료조명현우우상규치료조(χ2=6.274 P=0.043)。결론강화이도소치료유리우유선암합병당뇨병병인적술후절구유합,명현감소병발증적발생。
Objective To explore perioperative intensive insulin therapy on the efifcacy of rehabilitation in patients with breast cancer combined with diabetes. Methods 120 patients with breast cancer combined with diabetes underwent surgery were randomly divided into the group of intensive insulin therapy and the group of conventional insulin therapy in 2011 January to 2013 January. The postoperative drainage, fever and wound infection condition of the patients with breast cancer were observed. Results There are no obvious difference of the postoperative drainage volume in the patients between the group of intensive insulin therapy and the group of conventional treatment(χ2=1.564, P=0.458).The postoperative fever and wound infection condition in the group of intensive insulin therapy were obvious different than those of the group of conventional treatment (χ2=6.274, P=0.043). Conclusions Intensive insulin therapy was beniifcial to postoperative recovery of the patients with breast cancer combined with diabetes, and this therapy could reduce postoperative complications and the hospitalization expenses.